{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&tablingMemberConstituency=North+West+Norfolk&dateTabled=2019-03-13", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?houseId=1&tablingMemberConstituency=North+West+Norfolk&dateTabled=2019-03-13", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&tablingMemberConstituency=North+West+Norfolk&dateTabled=2019-03-13&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&houseId=1&tablingMemberConstituency=North+West+Norfolk&dateTabled=2019-03-13", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&tablingMemberConstituency=North+West+Norfolk&dateTabled=2019-03-13", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=1&tablingMemberConstituency=North+West+Norfolk&dateTabled=2019-03-13", "items" : [{"_about" : "http://data.parliament.uk/resources/1088440", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1088440/answer", "answerText" : {"_value" : "
The Medical Research Council (MRC) is part of the BEIS partner organisation, UK Research and Innovation. The MRC supports research relating to Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) in response to high-quality proposals from the research community.<\/p>
<\/p>
The MRC does not generally ring-fence funding for specific conditions, however CFS/ME is an identified priority area for the MRC. Proposals are particularly encouraged in areas that explore the underpinning mechanisms of CFS/ME (including immune dysregulation), pain, improved sub-phenotyping and stratification of CFS/ME disease, and mechanisms of CFS/ME in children.<\/p>
<\/p>
All proposals are subject to peer review and judged in open competition, with awards being made according to their scientific quality and importance to human health.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4021", "label" : {"_value" : "Biography information for Chris Skidmore"} } , "answeringMemberConstituency" : {"_value" : "Kingswood"} , "answeringMemberPrinted" : {"_value" : "Chris Skidmore"} , "dateOfAnswer" : {"_value" : "2019-03-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-03-20T11:25:25.853Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2019-03-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Chronic Fatigue Syndrome: Research"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the potential merits of ring-fencing Medical Research Council funds for biomedical research into ME in order to ensure that overall research funding for ME is proportional to that spent on research into similarly prevalent health conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1441", "label" : {"_value" : "Biography information for Lord Bellingham"} } , "tablingMemberConstituency" : {"_value" : "North West Norfolk"} , "tablingMemberPrinted" : [{"_value" : "Sir Henry Bellingham"} ], "uin" : "231931"} , {"_about" : "http://data.parliament.uk/resources/1088444", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1088444/answer", "answerText" : {"_value" : "
Ministers at the Department regularly meet with medical training bodies including the General Medical Council, to discuss many issues. However, there have been no recent discussions with medical training bodies to discuss the guidance on myalgic encephalomyelitis (ME).<\/p>
<\/p>
In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with chronic fatigue syndrome (CFS)/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide.<\/p>
<\/p>
The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the NHS and is a key part of general practitioners\u2019 qualifying exams.<\/p>
<\/p>
On 20 September 2017, the National Institute for Health and Care Excellence announced its decision to undertake a full update of the guideline, \u2018Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children\u2019, following a review of the latest available evidence on the diagnosis and management of CFS/ME and a public consultation. New guidance is expected in October 2020. More information on this decision can be found at the following link:<\/p>